NRC Health Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
NRC Health (NRC) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-03-05
- NRC Health unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $0.00.
- NRC Health unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2023 was $0.00.
- NRC Health unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- NRC Health unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2020 was $4.00K.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2026-03-05 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-17 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-03 | |
| 2020-12-31 | $4.00K 10-K · filed 2022-03-04 | |
| 2018-12-31 | $66.00K 10-K · filed 2020-03-06 | |
| 2017-12-31 | $7.00K 10-K · filed 2018-03-14 | |
| 2015-12-31 | $3.00K 10-K · filed 2017-03-03 | -$3.00K 10-K · filed 2016-03-04 |
| 2012-12-31 | -$9.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |